WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know.

Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.

Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.

Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.

For the Journal of the American Medical Association, Basser executive director Susan Domchek, MD, and Memorial Sloan Kettering's Mark Robson, MD, discuss limitations around the new United States Preventive Services Task Force guidelines for BRCA genetic testing.

Basser Center genetic counselors and investigators teamed up to analyze publicly available data for genes in which mutations are implicated in germline cancer susceptibility and establish a pipeline to automate clinical referral for evaluation of tumor-only genetic profiling.

In the Journal of Clinical Oncology, Basser Executive Director Susan Domchek, MD, discusses at-home genetic testing and the FDA’s regulatory language, which might confuse not only consumers, but also medical providers who are asked to interpret results and make clinical recommendations.

Susan Domchek, MD, executive director of the Basser Center, discusses the state of research showing PARP inhibitors can be effective for pancreatic patients with BRCA mutations.

Mainline Media News profiles the work of Dr. Ronny Drapkin, the Basser Center's Director of Gynecologic Cancer Research.

Alejandra Campoverdi, who has partnered with the Basser Center for our LATINX & BRCA initiative, speaks about her recent preventative mastectomy.

New findings from Penn Medicine researchers, including the study’s senior author, Basser’s Katherine L. Nathanson, MD, provide clues about immune response of tumors in patients with BRCA-related breast cancers. The research could shape treatment strategies and clinical trials.